SKIN CANCERS

In his presentation at the 2019 Annual Practical Recommendations in Immuno and Molecular Oncology Meetingi, Sanjiv S. Agarwala, MD, reviewed survival statistics of patients with melanoma being treated at different stages of their disease.

Consuming a diet rich in fiber could boost immunotherapy response in select patients with melanoma, according to early research findings.

Michael A. Postow, MD, shares advice to community oncologists on managing the side effects of immunotherapy in patients with melanoma.

The PD-1 inhibitor pembrolizumab has gained FDA approval as an adjuvant therapy for patients with high-risk stage III melanoma with lymph node involvement following complete resection.

More men than women are dying from malignant melanoma, according to findings presented at the National Cancer Research Institute Cancer Conference held in Glasgow, United Kingdom.

General Cancer

Skin Cancer

Genetic aberrations across cancer types were the driving force behind drug approvals in 2018.